128 related articles for article (PubMed ID: 17388235)
1. Gene therapy for laryngeal paralysis.
Shiotani A; Saito K; Araki K; Moro K; Watabe K
Ann Otol Rhinol Laryngol; 2007 Feb; 116(2):115-22. PubMed ID: 17388235
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryngeal nerve injury.
Araki K; Shiotani A; Watabe K; Saito K; Moro K; Ogawa K
Gene Ther; 2006 Feb; 13(4):296-303. PubMed ID: 16251996
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral gene transfer of BDNF and GDNF synergistically prevent motoneuron loss in the nucleus ambiguus.
Moro K; Shiotani A; Watabe K; Takeda Y; Saito K; Mori Y; Ogawa K
Brain Res; 2006 Mar; 1076(1):1-8. PubMed ID: 16473328
[TBL] [Abstract][Full Text] [Related]
4. A novel drug therapy for recurrent laryngeal nerve injury using T-588.
Mori Y; Shiotani A; Saito K; Araki K; Ikeda K; Nakagawa M; Watabe K; Ogawa K
Laryngoscope; 2007 Jul; 117(7):1313-8. PubMed ID: 17507828
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of the recurrent laryngeal nerve and the potential of gene therapy.
Heavner SB; Rubin AD; Fung K; Old M; Hogikyan ND; Feldman EL
Ann Otol Rhinol Laryngol; 2007 Jun; 116(6):441-8. PubMed ID: 17672247
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of glial-derived neurotrophic factor in rat laryngeal muscles during reinnervation.
Hernandez-Morato I; Isseroff TF; Sharma S; Pitman MJ
Laryngoscope; 2014 Dec; 124(12):2750-6. PubMed ID: 25220603
[TBL] [Abstract][Full Text] [Related]
7. Permanent rescue of lesioned neonatal motoneurons and enhanced axonal regeneration by adenovirus-mediated expression of glial cell-line-derived neurotrophic factor.
Baumgartner BJ; Shine HD
J Neurosci Res; 1998 Dec; 54(6):766-77. PubMed ID: 9856860
[TBL] [Abstract][Full Text] [Related]
8. Timing of human insulin-like growth factor-1 gene transfer in reinnervating laryngeal muscle.
Nakagawa H; Shiotani A; O'Malley BW; Coleman ME; Flint PW
Laryngoscope; 2004 Apr; 114(4):726-32. PubMed ID: 15064631
[TBL] [Abstract][Full Text] [Related]
9. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury.
Minnich JE; Mann SL; Stock M; Stolzenbach KA; Mortell BM; Soderstrom KE; Bohn MC; Kozlowski DA
Restor Neurol Neurosci; 2010; 28(3):293-309. PubMed ID: 20479525
[TBL] [Abstract][Full Text] [Related]
10. Collateral reinnervation by the superior laryngeal nerve after recurrent laryngeal nerve injury.
Hydman J; Mattsson P
Muscle Nerve; 2008 Oct; 38(4):1280-9. PubMed ID: 18816603
[TBL] [Abstract][Full Text] [Related]
11. Intravenous mesenchymal stem cell therapy after recurrent laryngeal nerve injury: a preliminary study.
Lerner MZ; Matsushita T; Lankford KL; Radtke C; Kocsis JD; Young NO
Laryngoscope; 2014 Nov; 124(11):2555-60. PubMed ID: 25043703
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral GDNF gene transfer prevents motoneuron loss in the nucleus ambiguus.
Saito K; Shiotani A; Watabe K; Moro K; Fukuda H; Ogawa K
Brain Res; 2003 Feb; 962(1-2):61-7. PubMed ID: 12543456
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of liposome-mediated glial cell line-derived neurotrophic factor gene transfer in vivo on motoneurons following spinal cord injury in rats.
Lu KW; Chen ZY; Hou TS
Chin J Traumatol; 2004 Oct; 7(5):275-9. PubMed ID: 15363220
[TBL] [Abstract][Full Text] [Related]
14. Potential for promoting recurrent laryngeal nerve regeneration by remote delivery of viral gene therapy.
Rubin AD; Hogikyan ND; Oh A; Feldman EL
Laryngoscope; 2012 Feb; 122(2):349-55. PubMed ID: 22241608
[TBL] [Abstract][Full Text] [Related]
15. A functional evaluation of ansa cervicalis nerve transfer for unilateral vocal cord paralysis: future directions for laryngeal reinnervation.
Green DC; Berke GS; Graves MC
Otolaryngol Head Neck Surg; 1991 Apr; 104(4):453-66. PubMed ID: 1903856
[TBL] [Abstract][Full Text] [Related]
16. Development and characterisation of an experimental recurrent laryngeal nerve injury model for the study of viral gene therapy.
Fung K; Hogikyan ND; Heavner SB; Ekbom D; Feldman EL
J Laryngol Otol; 2008 May; 122(5):500-5. PubMed ID: 17592655
[TBL] [Abstract][Full Text] [Related]
17. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor.
Blits B; Carlstedt TP; Ruitenberg MJ; de Winter F; Hermens WT; Dijkhuizen PA; Claasens JW; Eggers R; van der Sluis R; Tenenbaum L; Boer GJ; Verhaagen J
Exp Neurol; 2004 Oct; 189(2):303-16. PubMed ID: 15380481
[TBL] [Abstract][Full Text] [Related]
18. Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor.
Watabe K; Ohashi T; Sakamoto T; Kawazoe Y; Takeshima T; Oyanagi K; Inoue K; Eto Y; Kim SU
J Neurosci Res; 2000 May; 60(4):511-9. PubMed ID: 10797554
[TBL] [Abstract][Full Text] [Related]
19. Experimental crush of the equine recurrent laryngeal nerve: a study of normal and aberrant reinnervation.
Duncan ID; Baker GJ
Am J Vet Res; 1987 Mar; 48(3):431-8. PubMed ID: 3565901
[TBL] [Abstract][Full Text] [Related]
20. Delivery of an adenoviral vector to the crushed recurrent laryngeal nerve.
Rubin A; Mobley B; Hogikyan N; Bell K; Sullivan K; Boulis N; Feldman E
Laryngoscope; 2003 Jun; 113(6):985-9. PubMed ID: 12782809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
